Dublin, Ireland

Simon O'Reilly

This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Becton Dickinson and Company Limited. Active years: 2026.

USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 3.8

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Simon O'Reilly

Introduction

Simon O'Reilly is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of drug delivery devices, holding a total of 3 patents. His work focuses on improving the efficiency and safety of medical devices used for administering drugs.

Latest Patents

One of Simon's latest patents is titled "System and Method for Pressure Management for a Drug Delivery Device." This innovative method involves a pressure management technique that includes a pump, a fluid line, and a power source. The process entails delivering fluid through the fluid line via the pump, determining a parameter indicative of pressure within the fluid line, and checking if this parameter exceeds a pressure threshold level. If it does, the delivery of fluid is paused until a predetermined condition is satisfied, after which the delivery resumes.

Career Highlights

Simon O'Reilly is currently employed at Becton Dickinson and Company Limited, where he continues to develop cutting-edge technologies in the medical field. His expertise in pressure management systems has positioned him as a key player in the advancement of drug delivery methods.

Collaborations

Some of Simon's coworkers include Steve Beguin and Maurice Curtin, who contribute to the innovative environment at Becton Dickinson and Company Limited.

Conclusion

Simon O'Reilly's work exemplifies the impact of innovation in the medical device industry. His patents reflect a commitment to enhancing drug delivery systems, ultimately benefiting patient care and safety.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…